CC Sabathia is out until at least July with a right knee injury, but as more details emerge about the stem cell treatment he received it’s clear that the Yankees really have no firm idea of when he’ll be back on the mound.
Manager Joe Girardi more or less said as much yesterday in talking to Brendan Kuty of the Newark Star Ledger:
I think there’s always that possibility a player may not make it back. But I feel pretty good about he’s had done so far and the steps that were taken, and you just kind of keep your fingers crossed.
As far as quotes go, “there’s always that possibility a player may not make it back” and “you just kind of keep your fingers crossed” are not an encouraging combination.
Sabathia is out for a minimum of six weeks, at which point he’d need multiple minor-league rehab starts to build back his arm strength. And even if he does return early in the second half, Sabathia has a 4.87 ERA in 40 starts dating back to last season. He’s a huge question mark and the Yankees still owe him another $75 million or so.
The Dodgers have signed lefty Rich Hill to a three-year, $48 million contract.The deal was reported to be imminent over the weekend, but was finalized today following Hill’s physical.
Hill missed a good deal of time in 2016 with blister issues — and he’ll be 37-years-old on Opening Day — but when he was healthy he was fantastic, posting the best season in his 12-year career. He had a a 2.12 ERA and 129 strikeouts in 110.1 innings between the Athletics and Dodgers.
Along with a healthy Clayton Kershaw a maturing Julio Urias and Kenta Maeda, the Dodgers rotation looks to be a strength in 2017.
UPDATE: Buster Olney reports that a deal is in place pending a physical. The financial terms are not yet known. UPDATE: Joel Sherman of the New York Post hears it’s in the four-year, $62 million range. That will make him, temporarily at least, the highest-paid closer in baseball history.
12:15 PM: Ken Rosenthal reports that the San Francisco Giants are close to a deal with closer Mark Melancon.
Melancon had an outstanding 2016, posting a 1.64 ERA, 2.42 FIP and a 5.42 K/BB rate in 71.1 innings while saving 47 games for the Pirates and Nationals. You may recall that the Giants had a strong interest in Melancon last summer. It was a well-founded interest given the bullpen woes which waylaid San Francisco in the second half of last season and continued on into the playoffs.
The terms of the apparently impeding deal will be known soon enough, but Rosenthal reported yesterday that Melancon was fielding offers in the four-years, $60 million range. That’s a lot for a closer, but it’ll probably look like a bargain compared to the deals signed with the other two top closers on the market, Aroldis Chapman and Kenley Jansen. Some have speculated that Chapman could get a deal closer to $100 million than $50 million, though that seems optimistic.
What the past couple of seasons have shown, however, is that having a top bullpen will get you very, very far in Major League Baseball. Champan may have been gassed at the end of Game 7, but he was essential to the Cubs’ World Series title. Powerful bullpens gave the Royals a title in 2015 and the Indians an AL pennant this past year. A weak one was, obviously, the Giants’ achilles heel.
Their great need at the back end of the pen, according to Rosenthal’s report, is apparently about to be filled.